Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Conditions:   Bone Metastases;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate CancerInterventions:   Radiation: radiation therapy;   Other: laboratory biomarker analysisSponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI);   DendreonRecruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials